HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 25, 17228-17237, June 23, 2006

This Article Full Text Full Text (PDF) All Versions of this Article: 281/25/17228    most recent M602999200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feng, Y.-H. Articles by Gorodeski, G. I. Search for Related Content PubMed PubMed Citation Articles by Feng, Y.-H. Articles by Gorodeski, G. I. Social Bookmarking                      What's this?

A Truncated P2X₇ Receptor Variant (P2X_7-j) Endogenously Expressed in Cervical Cancer Cells Antagonizes the Full-length P2X₇ Receptor through Hetero-oligomerization^*

Ying-Hong Feng¹, Xin Li¹, Liqin Wang, Lingying Zhou, and George I. Gorodeski^¶||2

From the Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 and the Departments of Reproductive Biology, ^¶Physiology and Biophysics, and ^||Oncology, Case Western Reserve University, Cleveland, Ohio 44106

A truncated naturally occurring variant of the human receptor P2X₇ was identified in cancer cervical cells. The novel protein (P2X_7-j), a polypeptide of 258 amino acids, lacks the entire intracellular carboxyl terminus, the second transmembrane domain, and the distal third of the extracellular loop of the full-length P2X₇ receptor. The P2X_7-j was expressed in the plasma membrane; it showed diminished ligand-binding and channel function capacities and failed to form pores and mediate apoptosis in response to treatment with the P2X₇ receptor agonist benzoyl-ATP. The P2X_7-j interacted with the full-length P2X₇ in a manner suggesting heterooligomerization and blocked the P2X₇-mediated actions. Interestingly, P2X_7-j immunoreactivity and mRNA expression were similar in lysates of human cancer and normal cervical tissues, but fulllength P2X₇ immunoreactivity and mRNA expression were higher in normal than in cancer tissues, and cancer tissues lacked 205-kDa P2X₇ immunoreactivity suggesting lack of P2X₇ homo(tri)-oligomerization. These results identify a novel P2X₇ variant with apoptosis-inhibitory actions, and demonstrate a distinct regulatory property for a truncated variant to antagonize its full-length counterpart through hetero-oligomerization. This may represent a general paradigm for regulation of a protein function by its variant.

Received for publication, March 29, 2006 , and in revised form, April 18, 2006.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank^TM/EBI Data Bank with accession number(s) DQ399293 [GenBank] .

^* The work was supported in part by American Heart Association Scientist Development Grant 0030019N and NHLBI National Institutes of Health Grants HL65492 (to Y.-H. F.) and HD29924 and AG15955 (to G. I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Both authors contributed equally to this work.

² To whom correspondence should be addressed: University MacDonald Women's Hospital, University Hospitals of Cleveland, 11100 Euclid Ave., Cleveland, OH 44106. Tel.: 216-844-5977; Fax: 216-983-0091; E-mail: gig{at}cwru.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. C. S. Cross and S. High Dissecting the physiological role of selective transmembrane-segment retention at the ER translocon J. Cell Sci., June 1, 2009; 122(11): 1768 - 1777. [Abstract] [Full Text] [PDF]

				C. Xu, B. E. Shmukler, K. Nishimura, E. Kaczmarek, S. Rossetti, P. C. Harris, A. Wandinger-Ness, R. L. Bacallao, and S. L. Alper Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1464 - F1476. [Abstract] [Full Text] [PDF]

				L. Zhou, X. Qi, J. A. Potashkin, F. W. Abdul-Karim, and G. I. Gorodeski MicroRNAs miR-186 and miR-150 Down-regulate Expression of the Pro-apoptotic Purinergic P2X7 Receptor by Activation of Instability Sites at the 3'-Untranslated Region of the Gene That Decrease Steady-state Levels of the Transcript J. Biol. Chem., October 17, 2008; 283(42): 28274 - 28286. [Abstract] [Full Text] [PDF]

				C. Mayo, R. Ren, C. Rich, M. A. Stepp, and V. Trinkaus-Randall Regulation by P2X7: Epithelial Migration and Stromal Organization in the Cornea Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4384 - 4391. [Abstract] [Full Text] [PDF]

				D. Becker, R. Woltersdorf, W. Boldt, S. Schmitz, U. Braam, G. Schmalzing, and F. Markwardt The P2X7 Carboxyl Tail Is a Regulatory Module of P2X7 Receptor Channel Activity J. Biol. Chem., September 12, 2008; 283(37): 25725 - 25734. [Abstract] [Full Text] [PDF]

				T. Darville, L. Welter-Stahl, C. Cruz, A. A. Sater, C. W. Andrews Jr., and D. M. Ojcius Effect of the Purinergic Receptor P2X7 on Chlamydia Infection in Cervical Epithelial Cells and Vaginally Infected Mice J. Immunol., September 15, 2007; 179(6): 3707 - 3714. [Abstract] [Full Text] [PDF]

				X. Li, L. Zhou, Y.-H. Feng, F. W. Abdul-Karim, and G. I. Gorodeski The P2X7 Receptor: A Novel Biomarker of Uterine Epithelial Cancers. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1906 - 1913. [Abstract] [Full Text] [PDF]